FDA Adverse Event Malfunction Summary report: N

BD NANO¿ 2ND GEN PEN NEEDLE

MDR report key: 13534410 · Received February 15, 2022

Report

Report Number
9616656-2022-00172
Event Type
Malfunction
Date Received
February 15, 2022
Date of Event
February 2, 2022
Report Date
March 10, 2022
Manufacturer
BECTON DICKINSON AND CO.
Product Code
FMI
UDI-DI
00382903205509
PMA / PMN Number
K213156
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH LOT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 1145128. MEDICAL DEVICE EXPIRATION DATE: 2026-05-31. DEVICE MANUFACTURE DATE: 2021-05-25. MEDICAL DEVICE LOT #: 1132269. MEDICAL DEVICE EXPIRATION DATE: 2026-05-31. DEVICE MANUFACTURE DATE: 2021-05-12.

Additional Manufacturer Narrative · 0

DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH LOT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 1145128. MEDICAL DEVICE EXPIRATION DATE: 2026-05-31. DEVICE MANUFACTURE DATE: 2021-05-25. MEDICAL DEVICE LOT #: 1132269. MEDICAL DEVICE EXPIRATION DATE: 2026-05-31. DEVICE MANUFACTURE DATE: 2021-05-12.

Additional Manufacturer Narrative · 0

H6: INVESTIGATION SUMMARY: NO SAMPLES (INCLUDING PHOTOS) WERE RETURNED THEREFORE THE COMPLAINT COULD NOT BE CONFIRMED AND THE ROOT CAUSE IS UNDETERMINED. A LOT HISTORY REVIEW WAS CARRIED OUT AND NO RELATED NON CONFORMANCES WERE RAISED IN ASSOCIATION WITH THIS PACKAGED LOT CONCLUDING ALL INSPECTIONS WERE PERFORMED AS PER THE APPLICABLE OPERATIONS AND MET QC SPECIFICATIONS.

Description of Event or Problem · 0

IT WAS REPORTED THAT 4 BD NANO¿ 2ND GEN PEN NEEDLES WERE UNABLE TO DELIVER INSULIN. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CONSUMER REPORTED, NO INSULIN FLOW WHEN PRIMING. OVER THE PAST MANY MONTHS ABOUT 30% OF THE NEEDLES HAVE BEEN DEFECTIVE.

Description of Event or Problem · 0

IT WAS REPORTED THAT 4 BD NANO¿ 2ND GEN PEN NEEDLES WERE UNABLE TO DELIVER INSULIN. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CONSUMER REPORTED, NO INSULIN FLOW WHEN PRIMING. OVER THE PAST MANY MONTHS ABOUT 30% OF THE NEEDLES HAVE BEEN DEFECTIVE.

Description of Event or Problem · 0

IT WAS REPORTED THAT 4 BD NANO¿ 2ND GEN PEN NEEDLES WERE UNABLE TO DELIVER INSULIN. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CONSUMER REPORTED, NO INSULIN FLOW WHEN PRIMING. OVER THE PAST MANY MONTHS ABOUT 30% OF THE NEEDLES HAVE BEEN DEFECTIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
875711 BD NANO¿ 2ND GEN PEN NEEDLE HYPODERMIC SINGLE LUMEN NEEDLE FMI BECTON DICKINSON AND CO. 320550 SEE H10 00382903205509

Patients

Seq Age Sex Outcome Treatment
1 Unknown